$SMMT.US Ranked Positive On March 28th, 2024

Smart Insider $SMMT.US Ranked Positive On March 28th, 2024

$SMMT.US Ranked Positive On March 28th, 2024

Summit Therapeutic (SMMT US, +1, 28-Mar-24)

Ankur Dhingra¬†(CFO since 2022) purchased $375,000 of stock on¬†the 26th of March at $3.75, increasing his stake by 39%. This is much his largest purchase or subscription and also¬†much the highest price he has paid. His only previous clean purchase was for $44,000 of stock at $2.17 and it’s very¬†notable to see him now buying in size at a higher price.¬†

Mahkam Zanganeh (Co-CEO since 2022, joined 2020) purchased $411,000 of stock on the 26th of March. Whilst modest relative to her 3.6% stake and previous subscriptions, this is her first proper-sized clean purchase. 

We are ranking the stock +1.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.

If you are interested in our Stocks of the Week
those services may also be useful for you

Desktop
Service

Timely data delivery customised to every user, backed by analysis tools on our internal website

Signals
Data

We rank the stocks where transactions are most likely to indicate future share price performance

Shares
Buybacks

Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top